Keyphrases
Declarative Memory
100%
Subchronic
100%
Phencyclidine
100%
Ketamine
100%
Rapastinel
100%
Memory Deficits
100%
GLYX-13
100%
Novel Object Recognition
63%
Rodents
27%
N-methyl-D-aspartate Receptor (NMDAR)
27%
Rapid-acting Antidepressant
27%
Antidepressant Properties
27%
Antidepressants
18%
C57BL
18%
Clinical Application
9%
Atypical Antipsychotics
9%
Lurasidone
9%
Cognitive Impairment
9%
Partial Agonism
9%
Clinical Testing
9%
Antipsychotics
9%
Receptor Antagonist
9%
Amides
9%
Tetrapeptide
9%
Add-on Therapy
9%
Competitive Antagonist
9%
Non-competitive
9%
Glycine Site
9%
Cognitive Enhancement
9%
Non-ionotropic
9%
Neuroscience
Phencyclidine
100%
Ketamine
100%
Declarative Memory
100%
Rapastinel
100%
Antidepressant
36%
Dextro Aspartic Acid
27%
Antipsychotic
18%
Antidepressant
9%
Cognitive Disorders
9%
Lurasidone
9%
Glycine Receptor
9%
Partial Agonism
9%
Tetrapeptide
9%
Receptor Antagonist
9%
Ionotropic Effect
9%
Carboxamide
9%
Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Rapastinel
100%
Ketamine
100%
Phencyclidine
100%
Antidepressant
36%
Dextro Aspartic Acid
27%
C57BL 6 Mouse
18%
Atypical Antipsychotics
9%
Add on Therapy
9%
Antidepressant
9%
Receptor
9%
Cognitive Defect
9%
Antipsychotic
9%
Tetrapeptide
9%
Lurasidone
9%
Carboxamide
9%
Receptor Antagonist
9%
Glycine Receptor
9%